
Oral Oncology Reports, Journal Year: 2024, Volume and Issue: 11, P. 100579 - 100579
Published: July 3, 2024
• Study focused on depth-dependent PD-L1 sampling in HNSCC for PD-1/PD-L1 checkpoint inhibitor immunotherapy. Evaluated TPS and CPS values five patients using multiple tissue sections at specific intervals. The findings suggests further research variations near threshold values. It has potential more personalized effective immunotherapy strategies HNSCC.
Language: Английский